<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM (A) THE BALANCE SHEETS, STATEMENTS OF OPERATIONS AND STATEMENTS OF CASH FLOWS OF THORATEC LABORATORIES CORPORATION AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH (B) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED APRIL 1, 2000. </LEGEND> <MULTIPLIER> 1 <CURRENCY> US DOLLARS <PERIOD-TYPE> 3-MOS <FISCAL-YEAR-END> DEC-30-2000 <PERIOD-START> JAN-02-2000 <PERIOD-END> APR-01-2000 <EXCHANGE-RATE> 1 <CASH> 2,536,395 <SECURITIES> 0 <RECEIVABLES> 5,708,961 <ALLOWANCES> 0 <INVENTORY> 7,298,507 <CURRENT-ASSETS> 15,876,117 <PP&E> 12,287,096 <DEPRECIATION> (2,994,269) <TOTAL-ASSETS> 26,619,721 <CURRENT-LIABILITIES> 4,144,794 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 73,691,498 <OTHER-SE> (51,999,674) <TOTAL-LIABILITY-AND-EQUITY> 26,619,721 <SALES> 7,605,836 <TOTAL-REVENUES> 8,012,161 <CGS> 2,931,969 <TOTAL-COSTS> 2,931,969 <OTHER-EXPENSES> 4,368,717 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 0 <INCOME-PRETAX> 711,475 <INCOME-TAX> 62,901 <INCOME-CONTINUING> 648,574 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 648,574 <EPS-BASIC> .03 <EPS-DILUTED> .03